Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: Concurrent expression in cancer cells from primary tumour and metastatic lymph node - Université Sorbonne Paris Nord Accéder directement au contenu
Article Dans Une Revue Lung Cancer Année : 2007

Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: Concurrent expression in cancer cells from primary tumour and metastatic lymph node

Pierre Saintigny
Marianne Kambouchner
  • Fonction : Auteur
Madani Ly
  • Fonction : Auteur
Noëlia Gomes
  • Fonction : Auteur
Roger Vassy
  • Fonction : Auteur
Sébastien Czernichow
  • Fonction : Auteur
  • PersonId : 851964
Philippe Letoumelin
  • Fonction : Auteur
Jean-Luc Breau
  • Fonction : Auteur
Jean-François Bernaudin
  • Fonction : Auteur
  • PersonId : 1029284
Michel Kraemer
  • Fonction : Auteur

Résumé

SummaryIntroduction Investigation of the role of vascular endothelial growth factor-C (VEGF-C) and VEGF receptor-3 (VEGFR-3) in non-small-cell lung cancer (NSCLC) has mainly focused on lymph node (LN) metastasis related to lymphangiogenesis. However, the coexpression of VEGF-C/VEGFR-3 by tumour cells can independently play an important role. The present study was therefore designed to evaluate VEGF-C/VEGFR-3 coexpression in tumour cells from the primary tumour and corresponding LN metastases.Methods VEGF-C and VEGFR-3 expression in cancer cells were evaluated by immunohistochemistry in 92 NSCLC samples and 45 metastatic LNs. Ki67 expression and mitotic index (MI) in tumours and clinicopathological data were analysed concurrently.Results VEGFR-3 and VEGF-C expression were observed in 42% and 74% of tumours, respectively. Concurrent expression of VEGF-C and VEGFR-3, observed in 39% of tumours, was significantly associated with a higher proliferation rate and a higher incidence of LN metastases. VEGF-C expression in tumour cells was observed in 100% of metastatic LN and VEGF-C/VEGFR-3 coexpression was observed in 71% of metastatic LN. Finally, concurrent expression of VEGF-C/VEGFR-3 in the primary tumour was associated with poor disease-free survival on univariate analysis.Conclusion In NSCLC cancer cells, VEGF-C/VEGFR-3 coexpression suggests an autocrine/paracrine loop responsible for a high proliferation rate in tumour cells. As VEGF-C/VEGFR-3 coexpression is very frequent in metastatic LN tumour cells, it can be hypothesised that this coexpression participates in the growth of LN metastasis.

Dates et versions

hal-00416644 , version 1 (14-09-2009)

Identifiants

Citer

Pierre Saintigny, Marianne Kambouchner, Madani Ly, Noëlia Gomes, Odile Sainte-Catherine, et al.. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: Concurrent expression in cancer cells from primary tumour and metastatic lymph node. Lung Cancer, 2007, 58 (2), pp.205-213. ⟨10.1016/j.lungcan.2007.06.021⟩. ⟨hal-00416644⟩
114 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More